Iran can no longer enrich uranium or manufacture ballistic missiles, said Prime Minister Benjamin Netanyahu on Thursday.
“After 20 days, I can tell you — Iran today has no ability to enrich uranium, and no ability to produce ballistic…
News Source: www.timesofisrael.com
Anger at the government has spilled over at an Eid prayer event attended by the prime minister and home affairs minister, with a couple of attendees calling for the politicians to be removed from the Western Sydney mosque.
Anthony Albanese and…
News Source: www.abc.net.au
Omar Oswaldo Torres, the leader of the Los Mayos faction of the Sinaloa criminal network, was detained in the raid.
Published On 19 Mar 2026
Mexican authorities have revealed that 11 people were killed during a raid that resulted in the…
News Source: www.aljazeera.com
The largest project of its kind in Australia that will answer the biggest questions facing a generation today has set a new global benchmark for child health research, new findings reveal. The research, led from Murdoch Children’s Research…
News Source: medicalxpress.com
Short hair may be trending, but anybody dedicated to long hair knows new growth and retention are key to a healthy head of hair. Over the years, we’ve seen rosemary oil, peptides, and even red light therapy linked to hair growth, and now…
News Source: www.vogue.com
The US Director of National Intelligence says American and Israeli goals in the war on Iran are not the same.
News Source: www.aljazeera.com
When governing body offficials the Africa Cup of Nations title to Morocco, overturning Senegal’s victory two months after the chaotic final, football fans were stunned.
The impact of the decision could spread beyond sport and weaken the bond…
News Source: www.aljazeera.com
News Source: www.10tv.com
Summary: Music has long been the centerpiece of human rituals, from tribal dances to modern concerts. Now, a unique study has identified the biological “why.” The study reveals that listening to harmonically consonant chord progressions…
News Source: neurosciencenews.com
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a “masked T-cell engager.” This type of immunotherapy ignites our own immune arsenal to fight cancer.
News Source: medicalxpress.com